Prognostic Value of Ezrin in Various Cancers: A Systematic Review and Updated Meta-analysis

[1]  A META-ANALYSIS OF THE LITERATURE , 2017 .

[2]  Yunzhi Qin,et al.  Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas. , 2015, Experimental and molecular pathology.

[3]  S. Ferrari,et al.  Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response? , 2015, Orphanet Journal of Rare Diseases.

[4]  K. Jirström,et al.  Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker , 2014, Diagnostic Pathology.

[5]  C. Zhao,et al.  Expression of ezrin and moesin related to invasion, metastasis and prognosis of laryngeal squamous cell carcinoma. , 2014, Genetics and molecular research : GMR.

[6]  M. Uhlén,et al.  Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts , 2014, BMC Urology.

[7]  L. Sun,et al.  Akt/Ezrin Tyr353/NF-κB pathway regulates EGF-induced EMT and metastasis in tongue squamous cell carcinoma , 2013, British Journal of Cancer.

[8]  Prognostic implications of ezrin and phosphorylated ezrin expression in non-small cell lung cancer , 2014, BMC Cancer.

[9]  Kun Li,et al.  Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma , 2014, Medical Oncology.

[10]  Yulin Li,et al.  High expression of ezrin predicts poor prognosis in uterine cervical cancer , 2013, BMC Cancer.

[11]  S. Beghelli,et al.  Ezrin Expression Is an Independent Prognostic Factor in Gastro-intestinal Cancers , 2013, Journal of Gastrointestinal Surgery.

[12]  Yang Yao,et al.  Prognostic Value of Ezrin in Solid Tumors: A Meta-Analysis of the Literature , 2013, PloS one.

[13]  Lijuan Lin,et al.  Association between ezrin protein expression and the prognosis of colorectal adenocarcinoma. , 2013, Molecular medicine reports.

[14]  Shan-shui Xu,et al.  Expression and Functional Significance of Ezrin in Human Brain Astrocytoma , 2013, Cell Biochemistry and Biophysics.

[15]  M. Piris,et al.  Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas , 2013, Blood Cancer Journal.

[16]  C. Geng,et al.  Relationship of RhoA signaling activity with ezrin expression and its significance in the prognosis for breast cancer patients. , 2013, Chinese medical journal.

[17]  Wei Gao,et al.  Fascin-1, Ezrin and Paxillin Contribute to the Malignant Progression and Are Predictors of Clinical Prognosis in Laryngeal Squamous Cell Carcinoma , 2012, PloS one.

[18]  M. Oh,et al.  Clinicopathologic Implication of Ezrin Expression in Non-small Cell Lung Cancer , 2012, Korean journal of pathology.

[19]  Thomas M. Harris,et al.  Cytoplasmic Ezrin and Moesin Correlate with Poor Survival in Head and Neck Squamous Cell Carcinoma , 2012, Head and Neck Pathology.

[20]  P. Bendahl,et al.  Ezrin expression in rectal cancer predicts time to development of local recurrence , 2012, International Journal of Colorectal Disease.

[21]  Jingnan Shen,et al.  Expression change of ezrin as a prognostic factor in primary osteosarcoma , 2011, Medical oncology.

[22]  E. Li,et al.  Prognostic implication of ezrin expression in esophageal squamous cell carcinoma , 2011, Journal of surgical oncology.

[23]  Tinghuai Wang,et al.  17β-Estradiol Enhances Breast Cancer Cell Motility and Invasion via Extra-Nuclear Activation of Actin-Binding Protein Ezrin , 2011, PloS one.

[24]  Jin-Song Li,et al.  Expression of the membrane-cytoskeletal linker Ezrin in salivary gland adenoid cystic carcinoma. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[25]  Jie Ma,et al.  Ezrin is Associated with Gastric Cancer Progression and Prognosis , 2011, Pathology & Oncology Research.

[26]  A. Carneiro,et al.  Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas , 2011, Journal of Clinical Pathology.

[27]  G. Lin,et al.  Expression of ezrin correlates with poor prognosis of nasopharyngeal carcinoma , 2011, Tumor Biology.

[28]  F. Soares,et al.  Ezrin Expression as a Prognostic Marker in Colorectal Adenocarcinoma , 2011, Pathology & Oncology Research.

[29]  Y. Maehara,et al.  Different roles of S100P Overexpression in Intrahepatic Cholangiocarcinoma: Carcinogenesis of Perihilar Type and Aggressive Behavior of Peripheral Type , 2011, The American journal of surgical pathology.

[30]  K. Syrjänen,et al.  Preoperative radiotherapy modulates ezrin expression and its value as a predictive marker in patients with rectal cancer. , 2011, Human pathology.

[31]  M. Arpin,et al.  Emerging role for ERM proteins in cell adhesion and migration , 2011, Cell adhesion & migration.

[32]  Jun Yu,et al.  A microRNA contribution to aberrant Ras activation in gastric cancer. , 2011, American journal of translational research.

[33]  D. Moher,et al.  Nonalcoholic Fatty Liver Disease and Acute Ischemic Stroke , 2010 .

[34]  W. Kim,et al.  Prognostic implications of ezrin expression in human hepatocellular carcinoma , 2010, Molecular carcinogenesis.

[35]  B. de Camargo,et al.  Immunoexpression of Ezrin and CD44 in Patients With Osteosarcoma , 2010, Journal of pediatric hematology/oncology.

[36]  Chien-Feng Li,et al.  Prognostic Implication of Ezrin Overexpression in Myxofibrosarcomas , 2010, Annals of Surgical Oncology.

[37]  M. Georgescu,et al.  Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma. , 2010, Neuro-oncology.

[38]  S. Pang,et al.  Ezrin mediates c-Myc actions in prostate cancer cell invasion , 2010, Oncogene.

[39]  S. Morton,et al.  A Proposal for Reporting , 2010 .

[40]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[41]  S. Fais,et al.  The Janus‐faced role of ezrin in “linking” cells to either normal or metastatic phenotype , 2009, International journal of cancer.

[42]  F. Algaba,et al.  Protein expression patterns of ezrin are predictors of progression in T1G3 bladder tumours treated with nonmaintenance bacillus Calmette-Guérin. , 2009, European urology.

[43]  Chien-Feng Li,et al.  Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location , 2009, Modern Pathology.

[44]  J. Roh,et al.  Clinical value of ezrin expression in primary osteosarcoma. , 2009, Cancer research and treatment : official journal of Korean Cancer Association.

[45]  Zhong-ying Shen,et al.  Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells , 2009, International journal of cancer.

[46]  E. Li,et al.  Sp1 and AP-1 Regulate Expression of the Human Gene VIL2 in Esophageal Carcinoma Cells* , 2009, Journal of Biological Chemistry.

[47]  K. Syrjänen,et al.  Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. , 2008, Human pathology.

[48]  S. Ferrari,et al.  Prognostic significance of immunohistochemical expression of ezrin in non‐metastatic high‐grade osteosarcoma , 2008, Pediatric blood & cancer.

[49]  C. Chou,et al.  EGF upregulates Na+/H+ exchanger NHE1 by post‐translational regulation that is important for cervical cancer cell invasiveness , 2008, Journal of cellular physiology.

[50]  J. Gaudart,et al.  Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas , 2007, Virchows Archiv.

[51]  M. Sydes,et al.  Practical methods for incorporating summary time-to-event data into meta-analysis , 2007, Trials.

[52]  D. Jeon,et al.  Ezrin Expression Predicts Survival in Stage IIB Osteosarcomas , 2007, Clinical orthopaedics and related research.

[53]  Thomas J. Rosol,et al.  Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases , 2007, Clinical & Experimental Metastasis.

[54]  P. Dulguerov,et al.  Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy , 2006, Journal of Clinical Pathology.

[55]  M. Prystowsky,et al.  Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: Cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma , 2006, Head & neck.

[56]  J. Srivastava,et al.  The Nck-interacting kinase phosphorylates ERM proteins for formation of lamellipodium by growth factors , 2006, Proceedings of the National Academy of Sciences.

[57]  Steffen Hauptmann,et al.  Ezrin Promotes Ovarian Carcinoma Cell Invasion and Its Retained Expression Predicts Poor Prognosis in Ovarian Carcinoma , 2006, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[58]  S. Hauptmann,et al.  Ezrin expression is related to poor prognosis in FIGO stage I endometrioid carcinomas , 2006, Modern Pathology.

[59]  J. Palacios,et al.  Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas , 2006, Breast Cancer Research and Treatment.

[60]  Tse-Ching Chen,et al.  Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma. , 2005, Archives of surgery.

[61]  Wen-Hui Weng,et al.  Prognostic Impact of Immunohistochemical Expression of Ezrin in Highly Malignant Soft Tissue Sarcomas , 2005, Clinical Cancer Research.

[62]  A. Harris,et al.  REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British Journal of Cancer.

[63]  J. Srivastava,et al.  To whom correspondence should be addressed: M. Arpin , 2022 .

[64]  A. McClatchey,et al.  Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. , 2004, Developmental cell.

[65]  Stephen M Hewitt,et al.  The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis , 2004, Nature Medicine.

[66]  Javed Khan,et al.  Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators , 2004, Nature Medicine.

[67]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[68]  A. Vaheri,et al.  Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients. , 2003, Gynecologic oncology.

[69]  Paula R Williamson,et al.  Aggregate data meta‐analysis with time‐to‐event outcomes , 2002, Statistics in medicine.

[70]  A. Bretscher,et al.  ERM proteins and merlin: integrators at the cell cortex , 2002, Nature Reviews Molecular Cell Biology.

[71]  A. Gautreau,et al.  ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling. , 2002, Current opinion in cell biology.

[72]  T. Rutherford,et al.  Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1α and epidermal growth factor , 2001, Cancer.

[73]  A. Vaheri,et al.  Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. , 2001, Investigative ophthalmology & visual science.

[74]  S. Louvet-Vallée.  ERM proteins: From cellular architecture to cell signaling , 2000, Biology of the cell.

[75]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[76]  M. Parmar,et al.  Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.

[77]  A. Bretscher,et al.  Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures. , 1997, Journal of cell science.

[78]  J. Jääskeläinen,et al.  The ezrin protein family: membrane-cytoskeleton interactions and disease associations. , 1997, Current opinion in cell biology.

[79]  C. Gahmberg,et al.  Binding of the Cytoplasmic Domain of Intercellular Adhesion Molecule-2 (ICAM-2) to α-Actinin* , 1996, The Journal of Biological Chemistry.

[80]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[81]  A. Vaheri,et al.  Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family , 1994, The Journal of cell biology.

[82]  N. Sato,et al.  ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons , 1994, The Journal of cell biology.